Bone tissue engineering: A review in bone biomimetics and drug delivery strategies

Biotechnology Progress

Volumn 25, Issue 6, 2009, Pages 1539-1560

  Porter, Joshua R ^a   Ruckh, Timothy T ^a   Popat, Ketul C ^a  

^a Engineering Research Center and Hydraulics Laboratory   (United States)

Author keywords

Biomimetics; Bone tissue engineering; Drug delivery; Orthopedics

Indexed keywords

ANATOMICAL CHARACTERISTICS; BIOACTIVE MOLECULES; BIOLOGICAL RESPONSE; BONE REPAIR; BONE SCAFFOLDS; BONE TISSUE ENGINEERING; CANCER RECURRENCE; CHEMICAL ENVIRONMENT; CIS-PLATIN; ENGINEERING PRINCIPLES; EXTRACELLULAR MATRIX PRODUCTION; GOLD STANDARDS; HEALING PROCESS; HIERARCHICAL STRUCTURES; KEY TECHNOLOGIES; LOCAL DRUG DELIVERY; PHYSIO-CHEMICAL PROPERTIES; SYNTHETIC BONE SCAFFOLDS; SYNTHETIC MATERIALS; TISSUE INTEGRATION; TUMOR RESECTION;

BIOCOMPATIBILITY; BIODEGRADABLE POLYMERS; BIODEGRADATION; BIOLOGICAL MATERIALS; BIOMIMETICS; BONE; DRUG DELIVERY; ENGINEERING; ORTHOPEDICS; PLATINUM COMPOUNDS; SCAFFOLDS;

TISSUE ENGINEERING;

BIOMIMETIC MATERIAL;

ARTICLE; BIOMIMETICS; BONE; DRUG DELIVERY SYSTEM; HUMAN; METHODOLOGY; ORTHOPEDICS; TISSUE ENGINEERING;

BIOMIMETIC MATERIALS; BIOMIMETICS; BONE AND BONES; DRUG DELIVERY SYSTEMS; HUMANS; ORTHOPEDICS; TISSUE ENGINEERING;

EID: 73249127019     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1002/btpr.246     Document Type: Article

References (319)

1. American Academy of Orthopedic Surgeons. Facts on Orthopedic Surgeries. In: AAOS website (Available at: www.aaos. org/research/patientstats/). Cited August 20, 2008.
2. Kurtz SM, Ong KL, Schmier J, Mowat F, Saleh K, Dybvik E, Karrholm J, Garellick G, Havelin LI, Furnes O, Malchau H, Lau E. Future clinical and economic impact of revision total hip and knee arthroplasty. J Bone Joint Surg Am. 2007; 89(Suppl 3):144-151.
3. US Department of Health and Human Services. Healthcare Cost and Utilization Project (Available at: www.hcup-us.ahrq. gov/reports/statbriefs). Cited August 20, 2008.
4. Cattermole HR, Hardy JR, Gregg PJ. The footballer's fracture. Br J Sports Med. 1996;30:171-175.
5. Reuss BL, Cole JD. Effect of delayed treatment on open tibial shaft fractures. Am J Orthop. 2007;36:215-220. Biotechnol. Prog., 2009, Vol. 25, No. 6
6. Low K, Noblin JD, Browne JE, Barnthouse CD, Scott AR. Jones fractures in the elite football player. J Surg Orthop Adv. 2004;13:156-160.
7. Culpan P, Le Strat V, Piriou P, Judet T. Arthrodesis after failed total ankle replacement. J Bone Joint Surg Br. 2007;89:1178-1183.
8. Haidukewych GJ, Springer BD, Jacofsky DJ, Berry DJ. Total knee arthroplasty for salvage of failed internal fixation or non-union of the distal femur. J Arthroplasty. 2005;20:344-349.
9. Silber JS, Anderson DG, Daffner SD, Brislin BT, Leland JM, Hilibrand AS, Vaccaro AR, Albert TJ. Donor site morbidity after anterior iliac crest bone harvest for single-level anterior cervical discectomy and fusion. Spine. 2003;28:134-139.
10. Heary RF, Schlenk RP, Sacchieri TA, Barone D, Brotea C. Persistent iliac crest donor site pain: independent outcome assessment. Neurosurgery. 2002;50:510-516; discussion 516-517.
11. Kretlow JD, Mikos AG. Review: mineralization of synthetic polymer scaffolds for bone tissue engineering. Tissue Eng. 2007;13:927-938.
12. Nakajima T, Iizuka H, Tsutsumi S, Kayakabe M, Takagishi K. Evaluation of posterolateral spinal fusion using mesenchymal stem cells: differences with or without osteogenic differentiation. Spine. 2007;32:2432-2436.
13. Arrington ED, Smith WJ, Chambers HG, Bucknell AL, Davino NA. Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res. 1996;329:300-309.
14. Gitelis S, Saiz P. What's new in orthopedic surgery. J Am Coll Surg. 2002;194:788-791.
15. Banwart JC, Asher MA, Hassanein RS. Iliac crest bone graft harvest donor site morbidity. A statistical evaluation. Spine. 1995;20:1055-1060.
16. Mankin HJ, Hornicek FJ, Raskin KA. Infection in massive bone allografts. Clin Orthop Relat Res. 2005;432:210-216.
17. Nishida J, Shimamura T. Methods of reconstruction for bone defect after tumor excision: a review of alternatives. Med Sci Monit. 2008;14:RA107-RA113.
18. Hou CH, Yang RS, Hou SM. Hospital-based allogenic bone bank-10-year experience. J Hosp Infect. 2005;59:41-45.
19. Lanza RP, Butler DH, Borland KM, Staruk JE, Faustman DL, Solomon BA, Muller TE, Rupp RG, Maki T, Monaco AP, et al. Xenotransplantation of canine, bovine, and porcine islets in diabetic rats without immunosuppression. Proc Natl Acad Sci USA. 1991;88:11100-11104.
20. Butler D. Poll reveals backing for xenotransplants. Nature. 1998;391:315.
21. Yang YG, Sykes M. Xenotransplantation: current status and a perspective on the future. Nat Rev Immunol. 2007;7:519-531.
22. Yoo D, Giulivi A. Xenotransplantation and the potential risk of xenogeneic transmission of porcine viruses. Can J Vet Res. 2000;64:193-203.
23. Laurencin CT, El-Amin SF. Xenotransplantation in orthopedic surgery. J Am Acad Orthop Surg. 2008;16:4-8.
24. Langer R, Vacanti JP. Tissue engineering. Science. 1993;260: 920-926.
25. Albrektsson T, Johansson C. Osteoinduction, osteoconduction and osseointegration. Eur Spine J. 2001;10 (Suppl 2):S96-S101.
26. Mistry AS, Mikos AG. Tissue engineering strategies for bone regeneration. Adv Biochem Eng Biotechnol. 2005;94:1-22.
27. Service RF. Tissue engineers build new bone. Science. 2000;289:1498-1500.
28. Howard D, Buttery LD, Shakesheff KM, Roberts SJ. Tissue engineering: strategies, stem cells and scaffolds. J Anat. 2008;213:66-72.
29. Barrilleaux B, Phinney DG, Prockop DJ, O'Connor KC. Review: ex vivo engineering of living tissues with adult stem cells. Tissue Eng. 2006;12:3007-3019.
30. Kimelman N, Pelled G, Gazit Z, Gazit D. Applications of gene therapy and adult stem cells in bone bioengineering. Regen Med. 2006;1:549-561.
31. Logeart-Avramoglou D, Anagnostou F, Bizios R, Petite H. Engineering bone: challenges and obstacles. J Cell Mol Med. 2005;9:72-84.
32. van den Dolder J, Farber E, Spauwen PH, Jansen JA. Bone tissue reconstruction using titanium fiber mesh combined with rat bone marrow stromal cells. Biomaterials. 2003;24:1745-1750.
33. Mauney JR, Volloch V, Kaplan DL. Role of adult mesenchymal stem cells in bone tissue engineering applications: current status and future prospects. Tissue Eng. 2005;11:787-802.
34. Richards M, Huibregtse BA, Caplan AI, Goulet JA, Goldstein SA. Marrow-derived progenitor cell injections enhance new bone formation during distraction. J Orthop Res. 1999;17:900-908.
35. Kadiyala S, Young RG, Thiede MA, Bruder SP. Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. Cell Transplant. 1997;6:125-134.
36. Betz VM, Betz OB, Harris MB, Vrahas MS, Evans CH. Bone tissue engineering and repair by gene therapy. Front Biosci. 2008;13:833-841.
37. Phillips JE, Garcia AJ. Retroviral-mediated gene therapy for the differentiation of primary cells into a mineralizing osteoblastic phenotype. Methods Mol Biol. 2008;433:333-354.
38. Blum JS, Barry MA, Mikos AG, Jansen JA. In vivo evaluation of gene therapy vectors in ex vivo-derived marrow stromal cells for bone regeneration in a rat critical-size calvarial defect model. Hum Gene Ther. 2003;14:1689-1701.
39. Kofron MD, Laurencin CT. Bone tissue engineering by gene delivery. Adv Drug Deliv Rev. 2006;58:555-576.
40. Kimelman N, Pelled G, Helm GA, Huard J, Schwarz EM, Gazit D. Review: gene-and stem cell-based therapeutics for bone regeneration and repair. Tissue Eng. 2007;13:1135-1150.
41. Sikavitsas VI, Bancroft GN, Mikos AG. Formation of three-dimensional cell/polymer constructs for bone tissue engineering in a spinner flask and a rotating wall vessel bioreactor. J Biomed Mater Res. 2002;62:136-148.
42. Bancroft GN, Sikavitsas VI, Mikos AG. Design of a flow per-fusion bioreactor system for bone tissue-engineering applications. Tissue Eng. 2003;9:549-554.
43. Sikavitsas VI, Bancroft GN, Lemoine JJ, Liebschner MA, Dauner M, Mikos AG. Flow perfusion enhances the calcified matrix deposition of marrow stromal cells in biodegradable nonwoven fiber mesh scaffolds. Ann Biomed Eng. 2005;33:63-70.
44. Banfi A, Muraglia A, Dozin B, Mastrogiacomo M, Cancedda R, Quarto R. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: implications for their use in cell therapy. Exp Hematol. 2000;28: 707-715.
45. Banfi A, Bianchi G, Notaro R, Luzzatto L, Cancedda R, Quarto R. Replicative aging and gene expression in long-term cultures of human bone marrow stromal cells. Tissue Eng. 2002;8:901-910.
46. Simmons PJ, Torok-Storb B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood. 1991;78:55-62.
47. Bruder SP, Jaiswal N, Haynesworth SE. Growth kinetics, selfrenewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem. 1997;64:278-294.
48. Cartmell S. Controlled release scaffolds for bone tissue engineering. J Pharm Sci. 2009;98:430-441.
49. Holland TA, Mikos AG. Biodegradable polymeric scaffolds. Improvements in bone tissue engineering through controlled drug delivery. Adv Biochem Eng Biotechnol. 2006;102:161-185.
50. Skeletal System. Available at: www.web-books.com/eLibrary/ Medicine/Physiology/Skeletal/Skeletal.htm.
51. Flint A. Human Physiology. Kessinger Publishing Company; 2007.
52. Mackie EJ. Osteoblasts: novel roles in orchestration of skeletal architecture. Int J Biochem Cell Biol. 2003;35:1301-1305.
53. Jilka RL, Weinstein RS, Bellido T, Parfitt AM, Manolagas SC. Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. J Bone Miner Res. 1998;13:793-802.
54. Safadi FF, Xu J, Smock SL, Kanaan RA, Selim AH, Odgren PR, Marks SC, Jr, Owen TA, Popoff SN. Expression of connective tissue growth factor in bone: its role in osteoblast proliferation and differentiation in vitro and bone formation in vivo. J Cell Physiol. 2003;196:51-62.
55. Hadjidakis DJ, Androulakis II. Bone remodeling. Ann N Y Acad Sci. 2006;1092:385-396.
56. Parfitt AM. The cellular basis of bone remodeling: the quantum concept reexamined in light of recent advances in the cell biology of bone. Calcif Tissue Int. 1984;36(Suppl 1):S37-S45.
57. Lane NE. Therapy insight: osteoporosis and osteonecrosis in systemic lupus erythematosus. Nat Clin Pract Rheumatol. 2006;2:562-569.
58. Jacobs CR. The mechanobiology of cancellous bone structural adaptation. J Rehabil Res Dev. 2000;37:209-216.
59. Sikavitsas VI, Temenoff JS, Mikos AG. Biomaterials and bone mechanotransduction. Biomaterials. 2001;22:2581-2593.
60. Hayes WC. Basic Orthopedic Biomechanics. New York: Raven Press; 1991:93-142.
61. Hartgerink JD, Beniash E, Stupp SI. Self-assembly and mineralization of peptide-amphiphile nanofibers. Science. 2001;294: 1684-1688.
62. Goldstein SA, Wilson DL, Sonstegard DA, Matthews LS. The mechanical properties of human tibial trabecular bone as a function of metaphyseal location. J Biomech. 1983;16:965-969.
63. Cowin SC. Bone Biomechanics. Boca Raton: CRC Press; 1989: 97-157.
64. Cowin SC. Bone poroelasticity. J Biomech. 1999;32:217-238.
65. Dodd JS, Raleigh JA, Gross TS. Osteocyte hypoxia: a novel mechanotransduction pathway. Am J Physiol. 1999;277 (3 Part 1):C598-C602.
66. Thi MM, Kojima T, Cowin SC, Weinbaum S, Spray DC. Fluid shear stress remodels expression and function of junctional proteins in cultured bone cells. Am J Physiol Cell Physiol. 2003;284:C389-C403.
67. Weinbaum S, Cowin SC, Zeng Y. A model for the excitation of osteocytes by mechanical loading-induced bone fluid shear stresses. J Biomech. 1994;27:339-360.
68. Chambers TJ, Evans M, Gardner TN, Turner-Smith A, Chow JW. Induction of bone formation in rat tail vertebrae by mechanical loading. Bone Miner. 1993;20:167-178.
69. Murray DW, Rushton N. The effect of strain on bone cell prostaglandin E2 release: a new experimental method. Calcif Tissue Int. 1990;47:35-39.
70. Chen NX, Geist DJ, Genetos DC, Pavalko FM, Duncan RL. Fluid shear-induced NFkappaB translocation in osteoblasts is mediated by intracellular calcium release. Bone. 2003;33:399-410.
71. Toma CD, Ashkar S, Gray ML, Schaffer JL, Gerstenfeld LC. Signal transduction of mechanical stimuli is dependent on microfilament integrity: identification of osteopontin as a mechanically induced gene in osteoblasts. J Bone Miner Res. 1997;12:1626-1636.
72. Carvalho RS, Bumann A, Schaffer JL, Gerstenfeld LC. Pre-dominant integrin ligands expressed by osteoblasts show preferential regulation in response to both cell adhesion and mechanical perturbation. J Cell Biochem. 2002;84:497-508.
73. Lutolf MP, Hubbell JA. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol. 2005;23:47-55.
74. Athanasiou KA, Zhu C, Lanctot DR, Agrawal CM, Wang X. Fundamentals of biomechanics in tissue engineering of bone. Tissue Eng. 2000;6:361-381.
75. Glowacki J, Mizuno S. Collagen scaffolds for tissue engineering. Biopolymers. 2008;89:338-344.
76. McCann TJ, Mason WT, Meikle MC, McDonald F. A collagen peptide motif activates tyrosine kinase-dependent calcium signalling pathways in human osteoblast-like cells. Matrix Biol. 1997;16:273-283.
77. Maurer P, Hohenester E, Engel J. Extracellular calcium-binding proteins. Curr Opin Cell Biol. 1996;8:609-617.
78. Young MF, Kerr JM, Ibaraki K, Heegaard AM, Robey PG. Structure, expression, and regulation of the major noncollagenous matrix proteins of bone. Clin Orthop Relat Res. 1992;281:275-294.
79. Ducy P, Geoffroy V, Karsenty G. Study of osteoblast-specific expression of one mouse osteocalcin gene: characterization of the factor binding to OSE2. Connect Tissue Res. 1996;35:7-14.
80. de Oliveira PT, Nanci A. Nanotexturing of titanium-based surfaces upregulates expression of bone sialoprotein and osteopontin by cultured osteogenic cells. Biomaterials. 2004;25: 403-413.
81. McKee MD, Nanci A. Osteopontin: an interfacial extracellular matrix protein in mineralized tissues. Connect Tissue Res. 1996;35:197-205.
82. McKee MD, Nanci A. Osteopontin at mineralized tissue interfaces in bone, teeth, and osseointegrated implants: ultrastructural distribution and implications for mineralized tissue formation, turnover, and repair. Microsc Res Tech. 1996;33: 141-164.
83. Pietak AM, Sayer M. Functional atomic force microscopy investigation of osteopontin affinity for silicon stabilized tricalcium phosphate bioceramic surfaces. Biomaterials. 2006;27:3-14.
84. Baht GS, Hunter GK, Goldberg HA. Bone sialoprotein-collagen interaction promotes hydroxyapatite nucleation. Matrix Biol. 2008;27:600-608.
85. Halpert I, Sires UI, Roby JD, Potter-Perigo S, Wight TN, Shapiro SD, Welgus HG, Wickline SA, Parks WC. Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. Proc Natl Acad Sci USA. 1996;93:9748-9753.
86. Webster TJ, Schadler LS, Siegel RW, Bizios R. Mechanisms of enhanced osteoblast adhesion on nanophase alumina involve vitronectin. Tissue Eng. 2001;7:291-301.
87. Yang F, Williams CG, Wang DA, Lee H, Manson PN, Elisseeff J. The effect of incorporating RGD adhesive peptide in polyethylene glycol diacrylate hydrogel on osteogenesis of bone marrow stromal cells. Biomaterials. 2005;26:5991-5998.
88. Burdick JA, Anseth KS. Photoencapsulation of osteoblasts in injectable RGD-modified PEG hydrogels for bone tissue engineering. Biomaterials. 2002;23:4315-4323.
89. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992;69:11-25.
90. Garcia AJ, Reyes CD. Bio-adhesive surfaces to promote osteoblast differentiation and bone formation. J Dent Res. 2005;84:407-413.
91. Christenson EM, Anseth KS, van den Beucken JJ, Chan CK, Ercan B, Jansen JA, Laurencin CT, Li WJ, Murugan R, Nair LS, Ramakrishna S, Tuan RS, Webster TJ, Mikos AG. Nanobiomaterial applications in orthopedics. J Orthop Res. 2007;25:11-22.
92. Aubin JE. Advances in the osteoblast lineage. Biochem Cell Biol. 1998;76:899-910.
93. Karaplis AC. PTHrP: novel roles in skeletal biology. Curr Pharm Des. 2001;7:655-670.
94. Eanes ED. Biophysical aspects of lipid interaction with mineral: liposome model studies. Anat Rec. 1989;224:220-225.
95. Raggio CL, Boyan BD, Boskey AL. In vivo hydroxyapatite formation induced by lipids. J Bone Miner Res. 1986;1:409-415.
96. Merolli A, Bosetti M, Giannotta L, Lloyd AW, Denyer SP, Rhys-Williams W, Love WG, Gabbi C, Cacchioli A, Leali PT, Cannas M, Santin M. In vivo assessment of the osteointegrative potential of phosphatidylserine-based coatings. J Mater Sci Mater Med. 2006;17:789-794.
97. Bosetti M, Lloyd AW, Santin M, Denyer SP, Cannas M. Effects of phosphatidylserine coatings on titanium on inflammatory cells and cell-induced mineralisation in vitro. Biomaterials. 2005;26:7572-7578.
98. Storrie H, Stupp SI. Cellular response to zinc-containing organoapatite: an in vitro study of proliferation, alkaline phosphatase activity and biomineralization. Biomaterials. 2005;26: 5492-5499.
99. Beertsen W, van den Bos T. Alkaline phosphatase induces the mineralization of sheets of collagen implanted subcutaneously in the rat. J Clin Invest. 1992;89:1974-1980.
100. Anderson HC. Molecular biology of matrix vesicles. Clin Orthop Relat Res. 1995;314:266-280.
101. Nuttelman CR, Benoit DS, Tripodi MC, Anseth KS. The effect of ethylene glycol methacrylate phosphate in PEG hydrogels on mineralization and viability of encapsulated hMSCs. Biomaterials. 2006;27:1377-1386.
102. Pham QP, Kurtis Kasper F, Scott Baggett L, Raphael RM, Jansen JA, Mikos AG. The influence of an in vitro generated bone-like extracellular matrix on osteoblastic gene expression of marrow stromal cells. Biomaterials. 2008;29:2729-2739.
103. Sommerfeldt DW, Rubin CT. Biology of bone and how it orchestrates the form and function of the skeleton. Eur Spine J. 2001;10(Suppl 2):S86-S95.
104. Popat KC, Leoni L, Grimes CA, Desai TA. Influence of engineered titania nanotubular surfaces on bone cells. Biomaterials. 2007;28:3188-3197.
105. Wang J, Yang R, Gerstenfeld LC, Glimcher MJ. Characterization of demineralized bone matrix-induced osteogenesis in rat calvarial bone defects: III. Gene and protein expression. Calcif Tissue Int. 2000;67:314-320.
106. Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin Immunol. 2008;20:86-100.
107. Taton TA. Nanotechnology. Boning up on biology. Nature. 2001;412:491-492.
108. Pham QP, Sharma U, Mikos AG. Electrospun poly(epsilon-caprolactone) microfiber and multilayer nanofiber/microfiber scaffolds: characterization of scaffolds and measurement of cellular infiltration. Biomacromolecules. 2006;7:2796-2805.
109. Stevens MM, George JH. Exploring and engineering the cell surface interface. Science. 2005;310:1135-1138.
110. Staatz WD, Fok KF, Zutter MM, Adams SP, Rodriguez BA, Santoro SA. Identification of a tetrapeptide recognition sequence for the alpha 2 beta 1 integrin in collagen. J Biol Chem. 1991;266:7363-7367.
111. Lopez-Heredia MA, Sohier J, Gaillard C, Quillard S, Dorget M, Layrolle P. Rapid prototyped porous titanium coated with calcium phosphate as a scaffold for bone tissue engineering. Biomaterials. 2008;29:2608-2615.
112. Hughes TB. Bioabsorbable implants in the treatment of hand fractures: an update. Clin Orthop Relat Res. 2006;445:169-174.
113. Simon JA, Ricci JL, Di Cesare PE. Bioresorbable fracture fixation in orthopedics: a comprehensive review. Part I. Basic science and preclinical studies. Am J Orthop. 1997;26:665-671.
114. Simon JA, Ricci JL, Di Cesare PE. Bioresorbable fracture fixation in orthopedics: a comprehensive review. Part II. Clinical studies. Am J Orthop. 1997;26:754-762.
115. Zhang P, Hamamura K, Yokota H. A brief review of bone adaptation to unloading. Genomics Proteomics Bioinformatics. 2008;6:4-7.
116. Jacobs JJ, Sumner DR, Galante JO. Mechanisms of bone loss associated with total hip replacement. Orthop Clin North Am. 1993;24:583-590.
117. Hutmacher DW, Schantz JT, Lam CX, Tan KC, Lim TC. State of the art and future directions of scaffold-based bone engineering from a biomaterials perspective. J Tissue Eng Regen Med. 2007;1:245-260.
118. Tsubota K, Adachi T. Spatial and temporal regulation of cancellous bone structure: characterization of a rate equation of trabecular surface remodeling. Med Eng Phys. 2005;27:305-311.
119. Adachi T, Tsubota K, Tomita Y, Hollister SJ. Trabecular surface remodeling simulation for cancellous bone using microstructural voxel finite element models. J Biomech Eng. 2001;123:403-409.
120. Adachi T, Osako Y, Tanaka M, Hojo M, Hollister SJ. Framework for optimal design of porous scaffold microstructure by computational simulation of bone regeneration. Biomaterials. 2006;27:3964-3972.
121. El-Ghannam A. Bone reconstruction: from bioceramics to tissue engineering. Expert Rev Med Devices. 2005;2:87-101.
122. Paul W, Sharma CP. Ceramic drug delivery: a perspective. J Biomater Appl. 2003;17:253-264.
123. Klein C, Driessen AA, Degroot K, Vandenhooff A. Biodegradation behavior of various calcium-phosphate materials in bone tissue. J Biomed Mater Res. 1983;17:769-784.
124. Gauthier O, Bouler JM, Aguado E, Legeros RZ, Pilet P, Daculsi G. Elaboration conditions influence physicochemical properties and in vivo bioactivity of macroporous biphasic calcium phosphate ceramics. J Mater Sci Mater Med. 1999;10: 199-204.
125. Ducheyne P, Radin S, King L. The effect of calcium-phosphate ceramic composition and structure on in vitro behavior. Part 1: Dissolution. J Biomed Mater Res. 1993;27:25-34.
126. Royer A, Viguie JC, Heughebaert M, Heughebaert JC. Stoichiometry of hydroxyapatite-Influence on the flexural strength. J Mater Sci Mater Med. 1993;4:76-82.
127. Kohri M, Miki K, Waite DE, Nakajima H, Okabe T. In vitro stability of biphasic calcium phosphate ceramics. Biomaterials. 1993;14:299-304.
128. Eniwumide JO, Yuan H, Cartmell SH, Meijer GJ, de Bruijn JD. Ectopic bone formation in bone marrow stem cell seeded calcium phosphate scaffolds as compared to autograft and (cell seeded) allograft. Eur Cell Mater. 2007;14:30-38; discussion 39.
129. Kwon SH, Jun YK, Hong SH, Lee IS, Kim HE, Won YY. Calcium phosphate bioceramics with various porosities and dissolution rates. J Am Ceram Soc. 2002;85:3129-3131.
130. Kwon SH, Jun YK, Hong SH, Kim HE. Synthesis and dissolution behavior of beta-TCP and HA/beta-TCP composite powders. J Eur Ceram Soc. 2003;23:1039-1045.
131. Degroot K. Clinical-applications of calcium-phosphate biomaterials-A review. Ceram Int. 1993;19:363-366.
132. Ducheyne P. Bioceramics: material characteristics versus in vivo behavior. J Biomed Mater Res. 1987;21:219-236.
133. Rezwan K, Chen QZ, Blaker JJ, Boccaccini AR. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials. 2006;27:3413-3431.
134. Yaszemski MJ, Payne RG, Hayes WC, Langer R, Mikos AG. Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone. Biomaterials. 1996; 17:175-185.
135. Chlopek J, Morawska-Chochol A, Bajor G, Adwent M, Cieslik-Bielecka A, Cieslik M, Sabat D. The influence of carbon fibres on the resorption time and mechanical properties of the lactide-glycolide co-polymer. J Biomater Sci Polym Ed. 2007; 18:1355-1368.
136. Porter BD, Oldham JB, He SL, Zobitz ME, Payne RG, An KN, Currier BL, Mikos AG, Yaszemski MJ. Mechanical properties of a biodegradable bone regeneration scaffold. J Biomech Eng. 2000;122:286-288.
137. Wang J, Qu L, Meng X, Gao J, Li H, Wen G. Preparation and biological properties of PLLA/beta-TCP composites reinforced by chitosan fibers. Biomed Mater. 2008;3:25004.
138. Yu H, Matthew HW, Wooley PH, Yang SY. Effect of porosity and pore size on microstructures and mechanical properties of poly-epsilon-caprolactonehydroxyapatite composites. J Biomed Mater Res Part B Appl Biomater. 2008;86B:541-547.
139. Kaufman JD, Song J, Klapperich CM. Nanomechanical analysis of bone tissue engineering scaffolds. J Biomed Mater Res A. 2007;81:611-623.
140. Ji J, Ran J, Gou L, Wang F, Sun L. Microwave plasma sintering and in vitro study of porous HA/b-TCP biphasic bioceramics. Key Eng Mater. 2005;280-283, 1519-1524.
141. Shackelford JF. Bioceramics. Singapore: Gordon and Breach Science Publishers; 1999: Vol. 1, 82.
142. Gauthier O, Khairoun I, Bosco J, Obadia L, Bourges X, Rau C, Magne D, Bouler JM, Aguado E, Daculsi G, Weiss P. Noninvasive bone replacement with a new injectable calcium phosphate biomaterial. J Biomed Mater Res Part A. 2003;66:47-54.
143. LeGeros RZ. Properties of osteoconductive biomaterials: calcium phosphates. Clin Orthop Relat Res. 2002;395:81-98.
144. Kim HM, Himeno T, Kawashita M, Kokubo T, Nakamura T. The mechanism of biomineralization of bone-like apatite on synthetic hydroxyapatite: an in vitro assessment. J R Soc Interface. 2004;1:17-22.
145. Qian J, Kang Y, Zhang W, Li Z. Fabrication, chemical composition change and phase evolution of biomorphic hydroxyapatite. J Mater Sci Mater Med. 2008;19:3373-3383.
146. Ayers RA, Burkes DE, Gottoli G, Yi HC, Zhim F, Yahia L, Moore JJ. Combustion synthesis of porous biomaterials. J Biomed Mater Res A. 2007;81:634-643.
147. Lu J, Blary MC, Vavasseur S, Descamps M, Anselme K, Hardouin P. Relationship between bioceramics sintering and micro-particles-induced cellular damages. J Mater Sci Mater Med. 2004;15:361-365.
148. Fellah BH, Gauthier O, Weiss P, Chappard D, Layrolle P. Osteogenicity of biphasic calcium phosphate ceramics and bone autograft in a goat model. Biomaterials. 2008;29:1177-1188.
149. Ducheyne P, Qiu Q. Bioactive ceramics: the effect of surface reactivity on bone formation and bone cell function. Biomaterials. 1999;20:2287-2303.
150. Boccaccini AR, Blaker JJ. Bioactive composite materials for tissue engineering scaffolds. Expert Rev Med Devices. 2005; 2:303-317.
151. Bauer TW, Schils J. The pathology of total joint arthroplasty. Part I. Mechanisms of implant fixation. Skeletal Radiol. 1999; 28:423-432.
152. Yang C, Hillas PJ, Baez JA, Nokelainen M, Balan J, Tang J, Spiro R, Polarek JW. The application of recombinant human collagen in tissue engineering. BioDrugs. 2004;18:103-119.
153. Cen L, Liu W, Cui L, Zhang W, Cao Y. Collagen tissue engineering: development of novel biomaterials and applications. Pediatr Res. 2008;63:492-496.
154. Kanungo BP, Silva E, Van Vliet K, Gibson LJ. Characterization of mineralized collagen-glycosaminoglycan scaffolds for bone regeneration. Acta Biomater. 2008;4:490-503.
155. Venugopal J, Low S, Choon AT, Sampath Kumar TS, Ramakrishna S. Mineralization of osteoblasts with electrospun collagen/hydroxyapatite nanofibers. J Mater Sci Mater Med. 2008; 19:2039-2046.
156. Solchaga LA, Gao J, Dennis JE, Awadallah A, Lundberg M, Caplan AI, Goldberg VM. Treatment of osteochondral defects with autologous bone marrow in a hyaluronan-based delivery vehicle. Tissue Eng. 2002;8:333-347.
157. Ahmed TA, Dare EV, Hincke M. Fibrin: a versatile scaffold for tissue engineering applications. Tissue Eng Part B Rev. 2008;14:199-215.
158. Altman GH, Diaz F, Jakuba C, Calabro T, Horan RL, Chen J, Lu H, Richmond J, Kaplan DL. Silk-based biomaterials. Biomaterials. 2003;24:401-416.
159. Hu Y, Winn SR, Krajbich I, Hollinger JO. Porous polymer scaffolds surface-modified with arginine-glycine-aspartic acid enhance bone cell attachment and differentiation in vitro. J Biomed Mater Res A. 2003;64:583-590.
160. Reyes CD, Petrie TA, Burns KL, Schwartz Z, Garcia AJ. Biomolecular surface coating to enhance orthopedic tissue healing and integration. Biomaterials. 2007;28:3228-3235.
161. Solheim E. Growth factors in bone. Int Orthop. 1998;22:410-416.
162. Gao YH, Shinki T, Yuasa T, Kataoka-Enomoto H, Komori T, Suda T, Yamaguchi A. Potential role of cbfa1, an essential transcriptional factor for osteoblast differentiation, in osteoclastogenesis: regulation of mRNA expression of osteoclast differentiation factor (ODF). Biochem Biophys Res Commun. 1998; 252:697-702.
163. Khan SN, Bostrom MP, Lane JM. Bone growth factors. Orthop Clin North Am. 2000;31:375-388.
164. Reddi AH. Morphogenetic messages are in the extracellular matrix: biotechnology from bench to bedside. Biochem Soc Trans. 2000;28:345-349.
165. Urist MR. Bone: formation by autoinduction. Science. 1965; 150:893-899.
166. Hollinger JO, Leong K. Poly(alpha-hydroxy acids): carriers for bone morphogenetic proteins. Biomaterials. 1996;17:187-194.
167. Saito N, Okada T, Horiuchi H, Ota H, Takahashi J, Murakami N, Nawata M, Kojima S, Nozaki K, Takaoka K. Local bone formation by injection of recombinant human bone morphogenetic protein-2 contained in polymer carriers. Bone. 2003; 32:381-386.
168. Hollinger JO, Uludag H, Winn SR. Sustained release emphasizing recombinant human bone morphogenetic protein-2. Adv Drug Deliv Rev. 1998;31:303-318.
169. De Biase P, Capanna R. Clinical applications of BMPs. Injury. 2005;36 (Suppl 3):S43-S46.
170. Gonnerman KN, Brown LS, Chu TM. Effects of growth factors on cell migration and alkaline phosphatase release. Biomed Sci Instrum. 2006;42:60-65.
171. Kofron MD, Li X, Laurencin CT. Protein- and gene-based tissue engineering in bone repair. Curr Opin Biotechnol. 2004;15:399-405.
172. Cowan CM, Soo C, Ting K, Wu B. Evolving concepts in bone tissue engineering. Curr Top Dev Biol. 2005;66:239-285.
173. Franceschi RT, Wang D, Krebsbach PH, Rutherford RB. Gene therapy for bone formation: in vitro and in vivo osteogenic activity of an adenovirus expressing BMP7. J Cell Biochem. 2000;78:476-486.
174. Phillips JE, Gersbach CA, Garcia AJ. Virus-based gene therapy strategies for bone regeneration. Biomaterials. 2007;28: 211-229.
175. Galbraith CG, Sheetz MP. Cell traction. Curr Protoc Cell Biol. 2001;12:123.
176. Galbraith CG, Yamada KM, Sheetz MP. The relationship between force and focal complex development. J Cell Biol. 2002;159:695-705.
177. Galbraith CG, Sheetz MP. Forces on adhesive contacts affect cell function. Curr Opin Cell Biol. 1998;10:566-571.
178. Sheetz MP, Felsenfeld DP, Galbraith CG. Cell migration: regulation of force on extracellular-matrix-integrin complexes. Trends Cell Biol. 1998;8:51-54.
179. Desai TA. Micro- and nanoscale structures for tissue engineering constructs. Med Eng Phys. 2000;22:595-606.
180. Webster TJ, Ejiofor JU. Increased osteoblast adhesion on nanophase metals: Ti Ti6Al4V and CoCrMo. Biomaterials. 2004; 25:4731-4739.
181. Mata A, Boehm C, Fleischman AJ, Muschler GF, Roy S. Connective tissue progenitor cell growth characteristics on textured substrates. Int J Nanomedicine. 2007;2:389-406.
182. Popat KC, Daniels RH, Dubrow RS, Hardev V, Desai TA. Nanostructured surfaces for bone biotemplating applications. J Orthop Res. 2006;24:619-627.
183. Yang S, Leong KF, Du Z, Chua CK. The design of scaffolds for use in tissue engineering. Part I. Traditional factors. Tissue Eng. 2001;7:679-689.
184. Mo XM, Xu CY, Kotaki M, Ramakrishna S. Electrospun P(LLA-CL) nanofiber: a biomimetic extracellular matrix for smooth muscle cell and endothelial cell proliferation. Biomaterials. 2004;25:1883-1890.
185. Woodard JR, Hilldore AJ, Lan SK, Park CJ, Morgan AW, Eurell JA, Clark SG, Wheeler MB, Jamison RD, Wagoner Johnson AJ. The mechanical properties and osteoconductivity of hydroxyapatite bone scaffolds with multi-scale porosity. Biomaterials. 2007;28:45-54.
186. Hing KA, Annaz B, Saeed S, Revell PA, Buckland T. Microporosity enhances bioactivity of synthetic bone graft substitutes. J Mater Sci Mater Med. 2005;16:467-475.
187. Whang K, Healy KE, Elenz DR, Nam EK, Tsai DC, Thomas CH, Nuber GW, Glorieux FH, Travers R, Sprague SM. Engineering bone regeneration with bioabsorbable scaffolds with novel microarchitecture. Tissue Eng. 1999;5:35-51.
188. Bignon A, Chouteau J, Chevalier J, Fantozzi G, Carret JP, Chavassieux P, Boivin G, Melin M, Hartmann D. Effect of micro- and macroporosity of bone substitutes on their mechanical properties and cellular response. J Mater Sci Mater Med. 2003;14:1089-1097.
189. Boyan BD, Hummert TW, Dean DD, Schwartz Z. Role of material surfaces in regulating bone and cartilage cell response. Biomaterials. 1996;17:137-146.
190. Holmbom J, Sodergard A, Ekholm E, Martson M, Kuusilehto A, Saukko P, Penttinen R. Long-term evaluation of porous poly(epsilon-caprolactone-co-L-lactide) as a bone-filling material. J Biomed Mater Res A. 2005;75:308-315.
191. Walsh WR, Chapman-Sheath PJ, Cain S, Debes J, Bruce WJ, Svehla MJ, Gillies RM. A resorbable porous ceramic composite bone graft substitute in a rabbit metaphyseal defect model. J Orthop Res. 2003;21:655-661.
192. Yoshikawa H, Myoui A. Bone tissue engineering with porous hydroxyapatite ceramics. J Artif Organs. 2005;8:131-136.
193. Hayman EG, Pierschbacher MD, Suzuki S, Ruoslahti E. Vitronectin-a major cell attachment-promoting protein in fetal bovine serum. Exp Cell Res. 1985;160:245-258.
194. Horbett TA. The role of adsorbed proteins in animal cell adhesion. Surf Coll B. 1994;2:225-240.
195. Yoshimoto H, Shin YM, Terai H, Vacanti JP. A biodegradable nanofiber scaffold by electrospinning and its potential for bone tissue engineering. Biomaterials. 2003;24:2077-2082.
196. Ki CS, Park SY, Kim HJ, Jung HM, Woo KM, Lee JW, Park YH. Development of 3D nanofibrous fibroin scaffold with high porosity by electrospinning: implications for bone regeneration. Biotechnol Lett. 2008;30:405-410.
197. Smith LA, Ma PX. Nano-fibrous scaffolds for tissue engineering. Colloids Surf B Biointerf. 2004;39:125-131.
198. Murugan R, Ramakrishna S. Nano-featured scaffolds for tissue engineering: a review of spinning methodologies. Tissue Eng. 2006;12:435-447.
199. Kim GH. Electrospun PCL nanofibers with anisotropic mechanical properties as a biomedical scaffold. Biomed Mater. 2008;3:25010.
200. Porter JRH, Popat KC. Biodegradable poly(caprolactone) nanowire surfaces for bone tissue engineering applications. Biomaterials. 2009;30:780-788.
201. San Thian E, Ahmad Z, Huang J, Edirisinghe MJ, Jayasinghe SN, Ireland DC, Brooks RA, Rushton N, Bonfield W, Best SM. The role of electrosprayed apatite nanocrystals in guiding osteoblast behaviour. Biomaterials. 2008;29:1833-1843.
202. Leeuwenburgh SC, Wolke JG, Siebers MC, Schoonman J, Jansen JA. In vitro and in vivo reactivity of porous, electrosprayed calcium phosphate coatings. Biomaterials. 2006;27: 3368-3378.
203. Kumar R, Cheang P, Khor KA. Radio frequency (RF) suspension plasma sprayed ultra-fine hydroxyapatite (HA)/zirconia composite powders. Biomaterials. 2003;24:2611-2621.
204. Ono SS, Decher G. Preparation of ultrathin self-standing polyelectrolyte multilayer membranes at physiological conditions using pH-responsive film segments as sacrificial layers. Nano Lett. 2006;6:592-598.
205. Hosseinkhani H, Hosseinkhani M, Tian F, Kobayashi H, Tabata Y. Osteogenic differentiation of mesenchymal stem cells in self-assembled peptide-amphiphile nanofibers. Biomaterials. 2006;27:4079-4086.
206. Schneider G, Decher G. Functional core/shell nanoparticles via layer-by-layer assembly. Investigation of the experimental parameters for controlling particle aggregation and for enhancing dispersion stability. Langmuir. 2008;24:1778-1789.
207. Yao C, Webster TJ. Anodization: a promising nano-modification technique of titanium implants for orthopedic applications. J Nanosci Nanotechnol. 2006;6:2682-2692.
208. Kim HS, Yang Y, Koh JT, Lee KK, Lee DJ, Lee KM, Park SW. Fabrication and characterization of functionally graded nano-micro porous titanium surface by anodizing. J Biomed Mater Res B Appl Biomater. 2008;88:427-435.
209. Popat KC, Chatvanichkul KI, Barnes GL, Latempa TJ, Jr, Grimes CA, Desai TA. Osteogenic differentiation of marrow stromal cells cultured on nanoporous alumina surfaces. J Biomed Mater Res A. 2007;80:955-964.
210. Boudriot U, Dersch R, Greiner A, Wendorff JH. Electrospinning approaches toward scaffold engineering-a brief overview. Artif Organs. 2006;30:785-792.
211. Li WJ, Tuli R, Huang X, Laquerriere P, Tuan RS. Multilineage differentiation of human mesenchymal stem cells in a three-dimensional nanofibrous scaffold. Biomaterials. 2005;26: 5158-5166.
212. Shin M, Yoshimoto H, Vacanti JP. In vivo bone tissue engineering using mesenchymal stem cells on a novel electrospun nanofibrous scaffold. Tissue Eng. 2004;10:33-41.
213. Tao SL, Desai TA. Aligned arrays of biodegradable poly(epsilon-caprolactone) nanowires and nanofibers by template synthesis. Nano Lett. 2007;7:1463-1468.
214. Tuzlakoglu K, Bolgen N, Salgado AJ, Gomes ME, Piskin E, Reis RL. Nanoand micro-fiber combined scaffolds: a new architecture for bone tissue engineering. J Mater Sci Mater Med. 2005;16:1099-1104.
215. Srouji S, Kizhner T, Suss-Tobi E, Livne E, Zussman E. 3D Nanofibrous electrospun multilayered construct is an alternative ECM mimicking scaffold. J Mater Sci Mater Med. 2008;19:1249-1255.
216. Heo SJ, Kim SE, Wei J, Hyun YT, Yun HS, Kim DH, Shin JW, Shin JW. Fabrication and characterization of novel nano- and micro-HA/PCL composite scaffolds using a modified rapid prototyping process. J Biomed Mater Res A. 2008;89A:108-116.
217. Hutmacher DW. Scaffolds in tissue engineering bone and cartilage. Biomaterials. 2000;21:2529-2543.
218. Lucas PA, Laurencin C, Syftestad GT, Domb A, Goldberg VM, Caplan AI, Langer R. Ectopic induction of cartilage and bone by water-soluble proteins from bovine bone using a poly- anhydride delivery vehicle. J Biomed Mater Res. 1990;24:901-911.
219. Mori M, Isobe M, Yamazaki Y, Ishihara K, Nakabayashi N. Restoration of segmental bone defects in rabbit radius by bio- degradable capsules containing recombinant human bone morphogenetic protein-2. J Biomed Mater Res. 2000;50:191-198.
220. Babensee JE, McIntire LV, Mikos AG. Growth factor delivery for tissue engineering. Pharm Res. 2000;17:497-504.
221. Doll B, Sfeir C, Winn S, Huard J, Hollinger J. Critical aspects of tissue-engineered therapy for bone regeneration. Crit Rev Eukaryot Gene Expr. 2001;11:173-198.
222. Raiche AT, Puleo DA. In vitro effects of combined and sequential delivery of two bone growth factors. Biomaterials. 2004;25:677-685.
223. Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y, Arbel R, Aro H, Atar D, Bishay M, Borner MG, Chiron P, Choong P, Cinats J, Courtenay B, Feibel R, Geulette B, Gravel C, Haas N, Raschke M, Hammacher E, van der Velde D, Hardy P, Holt M, Josten C, Ketterl RL, Lindeque B, Lob G, Mathevon H, McCoy G, Marsh D, Miller R, Munting E, Oevre S, Nordsletten L, Patel A, Pohl A, Rennie W, Reynders P, Rommens PM, Rondia J, Rossouw WC, Daneel PJ, Ruff S, Ruter A, Santavirta S, Schildhauer TA, Gekle C, Schnettler R, Segal D, Seiler H, Snowdowne RB, Stapert J, Taglang G, Verdonk R, Vogels L, Weckbach A, Wentzensen A, Wisniewski T. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am. 2002;84A:2123-2134.
224. Friedlaender GE, Perry CR, Cole JD, Cook SD, Cierny G, Muschler GF, Zych GA, Calhoun JH, LaForte AJ, Yin S. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am. 2001;83A (Suppl 1, Part 2):S151-S158.
225. Jensen TB, Overgaard S, Lind M, Rahbek O, Bunger C, Soballe K. Osteogenic protein-1 increases the fixation of implants grafted with morcellised bone allograft and ProOsteon bone substitute: an experimental study in dogs. J Bone Joint Surg Br. 2007;89:121-126.
226. Jensen TB, Overgaard S, Lind M, Rahbek O, Bunger C, Soballe K. Osteogenic protein 1 device increases bone formation and bone graft resorption around cementless implants. Acta Orthop Scand. 2002;73:31-39.
227. Lind MC, Laursen M, Jensen TB, Overgaard S, Soballe K, Bunger CE. Stimulation of bone healing with growth factors in orthopedic surgery. Ugeskr Laeger. 2000;162:6399-6403.
228. Biondi M, Ungaro F, Quaglia F, Netti PA. Controlled drug delivery in tissue engineering. Adv Drug Deliv Rev. 2008;60:229-242.
229. Burdick JA, Mason MN, Hinman AD, Thorne K, Anseth KS. Delivery of osteoinductive growth factors from degradable PEG hydrogels influences osteoblast differentiation and mineralization. J Control Release. 2002;83:53-63.
230. von Burkersroda F, Schedl L, Gopferich A. Why degradable polymers undergo surface erosion or bulk erosion. Biomaterials. 2002;23:4221-4231.
231. Gopferich A. Mechanisms of polymer degradation and erosion. Biomaterials. 1996;17:103-114.
232. Kulkarni A, Reiche J, Kratz K, Kamusewitz H, Sokolov IM, Lendlein A. Enzymatic chain scission kinetics of poly(epsilon- caprolactone) monolayers. Langmuir. 2007;23:12202-12207.
233. Sinha VR, Bansal K, Kaushik R, Kumria R, Trehan A. Polyepsilon-caprolactone microspheres and nanospheres: an over- view. Int J Pharm. 2004;278:1-23.
234. Fay F, Linossier I, Langlois V, Renard E, Vallee-Rehel K. Degradation and controlled release behavior of epsilon-caprolactone copolymers in biodegradable antifouling coatings. Biomacromolecules. 2006;7:851-857.
235. Pena J, Corrales T, Izquierdo-Barba I, Serrano MC, Portoles MT, Pagani R, Vallet-Regi M. Alkaline-treated poly(epsilon- caprolactone) films: degradation in the presence or absence of fibroblasts. J Biomed Mater Res A. 2006;76:788-797.
236. Bolgen N, Menceloglu YZ, Acatay K, Vargel I, Piskin E. In vitro and in vivo degradation of non-woven materials made of poly(epsilon-caprolactone) nanofibers prepared by electrospinning under different conditions. J Biomater Sci Polym Ed. 2005;16:1537-1555.
237. Sun H, Mei L, Song C, Cui X, Wang P. The in vivo degradation, absorption and excretion of PCL-based implant. Biomaterials. 2006;27:1735-1740.
238. Yeo A, Rai B, Sju E, Cheong JJ, Teoh SH. The degradation profile of novel, bioresorbable PCL-TCP scaffolds: an in vitro and in vivo study. J Biomed Mater Res A. 2008;84:208-218.
239. Li S, Liu L, Garreau H, Vert M. Lipase-catalyzed biodegradation of poly(epsilon-caprolactone) blended with various polylactide-based polymers. Biomacromolecules. 2003;4:372-377.
240. Chawla JS, Amiji MM. Biodegradable poly(epsilon-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen. Int J Pharm. 2002;249:127-138.
241. Liu X, Ma PX. Polymeric scaffolds for bone tissue engineering. Ann Biomed Eng. 2004;32:477-486.
242. Suuronen R, Kallela I, Lindqvist C. Bioabsorbable plates and screws: current state of the art in facial fracture repair. J Craniomaxillofac Trauma. 2000;6:19-27; discussion 28-30.
243. Wuisman PI, Smit TH. Bioresorbable polymers: heading for a new generation of spinal cages. Eur Spine J. 2006;15:133-148.
244. Upton A, Roberts CL, Ryan M, Faulkner M, Reynolds M, Raynes-Greenow C. A randomised trial, conducted by mid- wives, of perineal repairs comparing a polyglycolic suture material and chromic catgut. Midwifery. 2002;18:223-229.
245. Meek MF, Coert JH. US food and drug administration/conformit Europe-approved absorbable nerve conduits for clinical repair of peripheral and cranial nerves. Ann Plast Surg. 2008;60:466-472.
246. Bergsma JE, de Bruijn WC, Rozema FR, Bos RR, Boering G. Late degradation tissue response to poly(L-lactide) bone plates and screws. Biomaterials. 1995;16:25-31.
247. Bergsma JE, Rozema FR, Bos RR, Boering G, de Bruijn WC, Pennings AJ. Biocompatibility study of as-polymerized poly(L-lactide) in rats using a cage implant system. J Biomed Mater Res. 1995;29:173-179.
248. Schliephake H, Weich HA, Schulz J, Gruber R. In vitro characterization of a slow release system of polylactic acid and rhBMP2. J Biomed Mater Res A. 2007;83:455-462.
249. Montjovent MO, Mathieu L, Schmoekel H, Mark S, Bourban PE, Zambelli PY, Laurent-Applegate LA, Pioletti DP. Repair of critical size defects in the rat cranium using ceramic-reinforced PLA scaffolds obtained by supercritical gas foaming. J Biomed Mater Res A. 2007;83:41-51.
250. Schliephake H, Weich HA, Dullin C, Gruber R, Frahse S. Mandibular bone repair by implantation of rhBMP-2 in a slow release carrier of polylactic acid-an experimental study in rats. Biomaterials. 2008;29:103-110.
251. Middleton JC, Tipton AJ. Synthetic biodegradable polymers as orthopedic devices. Biomaterials. 2000;21:2335-2346.
252. Marra KG, Szem JW, Kumta PN, DiMilla PA, Weiss LE. In vitro analysis of biodegradable polymer blend/hydroxyapatite composites for bone tissue engineering. J Biomed Mater Res. 1999;47:324-335.
253. Quaglia F, Ostacolo L, Nese G, De Rosa G, La Rotonda MI, Palumbo R, Maglio G. Microspheres made of poly(epsilon- caprolactone)-based amphiphilic copolymers: potential in sustained delivery of proteins. Macromol Biosci. 2005;5:945-954.
254. van de Weert M, Hennink WE, Jiskoot W. Protein instability in poly(lactic-co-glycolic acid) microparticles. Pharm Res. 2000;17:1159-1167.
255. Rai B, Teoh SH, Ho KH, Hutmacher DW, Cao T, Chen F, Yacob K. The effect of rhBMP-2 on canine osteoblasts seeded onto 3D bioactive polycaprolactone scaffolds. Biomaterials. 2004;25:5499-5506.
256. Rai B, Teoh SH, Ho KH. An in vitro evaluation of PCL-TCP composites as delivery systems for platelet-rich plasma. J Control Release. 2005;107:330-342.
257. Rai B, Oest ME, Dupont KM, Ho KH, Teoh SH, Guldberg RE. Combination of platelet-rich plasma with polycaprolactone-tricalcium phosphate scaffolds for segmental bone defect repair. J Biomed Mater Res A. 2007;81:888-899.
258. Rai B, Ho KH, Lei Y, Si-Hoe KM, Jeremy Teo CM, Yacob KB, Chen F, Ng FC, Teoh SH. Polycaprolactone-20% tricalcium phosphate scaffolds in combination with platelet-rich plasma for the treatment of critical-sized defects of the mandible: a pilot study. J Oral Maxillofac Surg. 2007;65:2195-2205.
259. Santiago LY, Nowak RW, Peter Rubin J, Marra KG. Peptidesurface modification of poly(caprolactone) with laminin- derived sequences for adipose-derived stem cell applications. Biomaterials. 2006;27:2962-2969.
260. Miyamoto S, Takaoka K, Okada T, Yoshikawa H, Hashimoto J, Suzuki S, Ono K. Polylactic acid-polyethylene glycol block copolymer. A new biodegradable synthetic carrier for bone morphogenetic protein. Clin Orthop Relat Res. 1993;294:333-343.
261. Yoon SJ, Park KS, Kim MS, Rhee JM, Khang G, Lee HB. Repair of diaphyseal bone defects with calcitriol-loaded PLGA scaffolds and marrow stromal cells. Tissue Eng. 2007;13: 1125-1133.
262. Richardson TP, Peters MC, Ennett AB, Mooney DJ. Polymeric system for dual growth factor delivery. Nat Biotechnol. 2001;19:1029-1034.
263. Virto MR, Elorza B, Torrado S, Elorza Mde L, Frutos G. Improvement of gentamicin poly(D,L-lactic-co-glycolic acid) microspheres for treatment of osteomyelitis induced by orthopedic procedures. Biomaterials. 2007;28:877-885.
264. Liu SJ, Chi PS, Lin SS, Ueng SW, Chan EC, Chen JK. Novel solvent-free fabrication of biodegradable poly-lactic-glycolic acid (PLGA) capsules for antibiotics and rhBMP-2 delivery. Int J Pharm. 2007;330:45-53.
265. Nie H, Wang CH. Fabrication and characterization of PLGA/ HAp composite scaffolds for delivery of BMP-2 plasmid DNA. J Control Release. 2007;120:111-121.
266. Leach JK, Kaigler D, Wang Z, Krebsbach PH, Mooney DJ. Coating of VEGF-releasing scaffolds with bioactive glass for angiogenesis and bone regeneration. Biomaterials. 2006;27: 3249-3255.
267. Murphy WL, Peters MC, Kohn DH, Mooney DJ. Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials. 2000;21:2521-2527.
268. Richardson TP, Murphy WL, Mooney DJ. Polymeric delivery of proteins and plasmid DNA for tissue engineering and gene therapy. Crit Rev Eukaryot Gene Expr. 2001;11:47-58.
269. Whang K, Tsai DC, Nam EK, Aitken M, Sprague SM, Patel PK, Healy KE. Ectopic bone formation via rhBMP-2 delivery from porous bioabsorbable polymer scaffolds. J Biomed Mater Res. 1998;42:491-499.
270. Link DP, van den Dolder J, van den Beucken JJ, Cuijpers VM, Wolke JG, Mikos AG, Jansen JA. Evaluation of the biocompatibility of calcium phosphate cement/PLGA microparticle composites. J Biomed Mater Res A. 2008;87A:760-769.
271. Peter SJ, Lu L, Kim DJ, Stamatas GN, Miller MJ, Yaszemski MJ, Mikos AG. Effects of transforming growth factor beta1 released from biodegradable polymer microparticles on marrow stromal osteoblasts cultured on poly(propylene fumarate) substrates. J Biomed Mater Res. 2000;50:452-462.
272. Jiang T, Abdel-Fattah WI, Laurencin CT. In vitro evaluation of chitosan/poly(lactic acid-glycolic acid) sintered microsphere scaffolds for bone tissue engineering. Biomaterials. 2006;27: 4894-4903.
273. Meinel L, Illi OE, Zapf J, Malfanti M, Peter Merkle H, Gander B. Stabilizing insulin-like growth factor-I in poly(D,L-lactide- co-glycolide) microspheres. J Control Release. 2001;70:193-202.
274. Zhao L, He C, Gao Y, Cen L, Cui L, Cao Y. Preparation and cytocompatibility of PLGA scaffolds with controllable fiber morphology and diameter using electrospinning method. J Biomed Mater Res B Appl Biomater. 2008;87B:26-34.
275. Nie H, Soh BW, Fu YC, Wang CH. Three-dimensional fibrous PLGA/HAp composite scaffold for BMP-2 delivery. Biotechnol Bioeng. 2008;99:223-234.
276. Yixiang D, Yong T, Liao S, Chan CK, Ramakrishna S. Degradation of electrospun nanofiber scaffold by short wave length ultraviolet radiation treatment and its potential applications in tissue engineering. Tissue Eng Part A. 2008;14:1321-1329.
277. Wu L, Zhang H, Zhang J, Ding J. Fabrication of three-dimensional porous scaffolds of complicated shape for tissue engineering. Part I. Compression molding based on flexible-rigid combined mold. Tissue Eng. 2005;11:1105-1114.
278. Kempen DH, Lu L, Hefferan TE, Creemers LB, Maran A, Classic KL, Dhert WJ, Yaszemski MJ. Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering. Biomaterials. 2008;29:3245-3252.
279. Jeon O, Song SJ, Yang HS, Bhang SH, Kang SW, Sung MA, Lee JH, Kim BS. Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery. Biochem Biophys Res Commun. 2008;369: 774-780.
280. Kim SE, Jeon O, Lee JB, Bae MS, Chun HJ, Moon SH, Kwon IK. Enhancement of ectopic bone formation by bone morphogenetic protein-2 delivery using heparin-conjugated PLGA nanoparticles with transplantation of bone marrow-derived mesenchymal stem cells. J Biomed Sci. 2008;15:771-777.
281. Chung YI, Ahn KM, Jeon SH, Lee SY, Lee JH, Tae G. Enhanced bone regeneration with BMP-2 loaded functional nanoparticle-hydrogel complex. J Control Release. 2007;121: 91-99.
282. Jeon O, Song SJ, Kang SW, Putnam AJ, Kim BS. Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(L-lactic-coglycolic acid) scaffold. Biomaterials. 2007;28:2763-2771.
283. Edlund U, Danmark S, Albertsson AC. A strategy for the covalent functionalization of resorbable polymers with heparin and osteoinductive growth factor. Biomacromolecules. 2008;9: 901-905.
284. Peter SJ, Miller MJ, Yasko AW, Yaszemski MJ, Mikos AG. Polymer concepts in tissue engineering. J Biomed Mater Res. 1998;43:422-427.
285. Kato M, Toyoda H, Namikawa T, Hoshino M, Terai H, Miyamoto S, Takaoka K. Optimized use of a biodegradable polymer as a carrier material for the local delivery of recombinant human bone morphogenetic protein-2 (rhBMP-2). Biomaterials. 2006;27:2035-2041.
286. Kaito T, Myoui A, Takaoka K, Saito N, Nishikawa M, Tamai N, Ohgushi H, Yoshikawa H. Potentiation of the activity of bone morphogenetic protein-2 in bone regeneration by a PLA- PEG/hydroxyapatite composite. Biomaterials. 2005;26:73-79.
287. Bourque WT, Gross M, Hall BK. Expression of four growth factors during fracture repair. Int J Dev Biol. 1993;37:573-579.
288. Bostrom MP, Lane JM, Berberian WS, Missri AA, Tomin E, Weiland A, Doty SB, Glaser D, Rosen VM. Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing. J Orthop Res. 1995;13:357-367.
289. Yeh LC, Adamo ML, Olson MS, Lee JC. Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation. Endocrinology. 1997;138:4181-4190.
290. Yeh LC, Lee JC. Co-transfection with the osteogenic protein (OP)-1 gene and the insulin-like growth factor (IGF)-I gene enhanced osteoblastic cell differentiation. Biochim Biophys Acta. 2006;1763:57-63.
291. Schmidmaier G, Lucke M, Schwabe P, Raschke M, Haas NP, Wildemann B. Collective review: bioactive implants coated with poly(D,L-lactide) and growth factors IGF-I, TGF-beta1, or BMP-2 for stimulation of fracture healing. J Long Term Eff Med Implants. 2006;16:61-69.
292. Schmidmaier G, Wildemann B, Gabelein T, Heeger J, Kandziora F, Haas NP, Raschke M. Synergistic effect of IGF-I and TGF-beta1 on fracture healing in rats: single versus combined application of IGF-I and TGF-beta1. Acta Orthop Scand. 2003;74:604-610.
293. Chen RR, Silva EA, Yuen WW, Mooney DJ. Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation. Pharm Res. 2007;24:258-264.
294. Leach JK. Multifunctional cell-instructive materials for tissue regeneration. Regen Med. 2006;1:447-455.
295. Salvay DM, Shea LD. Inductive tissue engineering with protein and DNA-releasing scaffolds. Mol Biosyst. 2006;2:36-48.
296. Buket Basmanav F, Kose GT, Hasirci V. Sequential growth factor delivery from complexed microspheres for bone tissue engineering. Biomaterials. 2008;29:4195-4204.
297. Sill TJ, von Recum HA. Electrospinning: applications in drug delivery and tissue engineering. Biomaterials. 2008;29:1989-2006.
298. Piskin E, Isoglu IA, Bolgen N, Vargel I, Griffiths S, Cavusoglu T, Korkusuz P, Guzel E, Cartmell S. In vivo performance of simvastatin-loaded electrospun spiral-wound polycaprolactone scaffolds in reconstruction of cranial bone defects in the rat model. J Biomed Mater Res A. 2009 (in press).
299. Kato Y, Onishi H, Machida Y. Application of chitin and chitosan derivatives in the pharmaceutical field. Curr Pharm Biotechnol. 2003;4:303-309.
300. Murphy WL, Mooney DJ. Controlled delivery of inductive proteins, plasmid DNA and cells from tissue engineering matrices. J Periodontal Res. 1999;34:413-419.
301. Zilberman M, Elsner JJ. Antibiotic-eluting medical devices for various applications. J Control Release. 2008;130:202-215.
302. Segreti J, Nelson JA, Trenholme GM. Prolonged suppressive antibiotic therapy for infected orthopedic prostheses. Clin Infect Dis. 1998;27:711-713.
303. Albuhairan B, Hind D, Hutchinson A. Antibiotic prophylaxis for wound infections in total joint arthroplasty: a systematic review. J Bone Joint Surg Br. 2008;90:915-919.
304. Kuper M, Rosenstein A. Infection prevention in total knee and total hip arthroplasties. Am J Orthop. 2008;37:E2-E5.
305. Price JS, Tencer AF, Arm DM, Bohach GA. Controlled release of antibiotics from coated orthopedic implants. J Biomed Mater Res. 1996;30:281-286.
306. Naraharisetti PK, Guan Lee HC, Fu YC, Lee DJ, Wang CH. In vitro and in vivo release of gentamicin from biodegradable discs. J Biomed Mater Res B Appl Biomater. 2006;77:329-337.
307. Li H, Chang J. Preparation, characterization and in vitro release of gentamicin from PHBV/wollastonite composite microspheres. J Control Release. 2005;107:463-473.
308. Ramchandani M, Robinson D. In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants. J Control Release. 1998;54:167-175.
309. Rougraff BT, Simon MA, Kneisl JS, Greenberg DB, Mankin HJ. Limb salvage compared with amputation for osteosarcoma of the distal end of the femur. A long-term oncological, functional, and quality-of-life study. J Bone Joint Surg Am. 1994; 76:649-656.
310. Withrow SJ, Liptak JM, Straw RC, Dernell WS, Jameson VJ, Powers BE, Johnson JL, Brekke JH, Douple EB. Biodegradable cisplatin polymer in limb-sparing surgery for canine osteosarcoma. Ann Surg Oncol. 2004;11:705-713.
311. Ehrhart N, Dernell WS, Ehrhart EJ, Hutchison JM, Douple EB, Brekke JH, Straw RC, Withrow SJ. Effects of a controlled-release cisplatin delivery system used after resection of mammary carcinoma in mice. Am J Vet Res. 1999;60:1347-1351.
312. Dernell WS, Withrow SJ, Straw RC, Powers BE, Drekke JH, Lafferty M. Intracavitary treatment of soft tissue sarcomas in dogs using cisplatin in a biodegradable polymer. Anticancer Res. 1997;17:4499-4505.
313. Lin WJ, Yu CC. Comparison of protein loaded poly(epsilon- caprolactone) microparticles prepared by the hot-melt technique. J Microencapsul. 2001;18:585-592.
314. Mooney DJ, Baldwin DF, Suh NP, Vacanti JP, Langer R. Novel approach to fabricate porous sponges of poly(D,L-lactic-co-glycolic acid) without the use of organic solvents. Biomaterials. 1996;17:1417-1422.
315. Hile DD, Pishko MV. Solvent-free protein encapsulation within biodegradable polymer foams. Drug Deliv. 2004;11:287-293.
316. Miyai T, Ito A, Tamazawa G, Matsuno T, Sogo Y, Nakamura C, Yamazaki A, Satoh T. Antibiotic-loaded poly-epsilon-caprolactone and porous beta-tricalcium phosphate composite for treating osteomyelitis. Biomaterials. 2008;29:350-358.
317. Jameela SR, Suma N, Jayakrishnan A. Protein release from poly(epsilon-caprolactone) microspheres prepared by melt encapsulation and solvent evaporation techniques: a comparative study. J Biomater Sci Polym Ed. 1997;8:457-466.
318. Kim SS, Sun Park M, Jeon O, Yong Choi C, Kim BS. Poly (lactide-co-glycolide)/hydroxyapatite composite scaffolds for bone tissue engineering. Biomaterials. 2006;27:1399-1409.
319. Lin WJ, Kang WW. Comparison of chitosan and gelatin coated microparticles: prepared by hot-melt method. J Microencapsul. 2003;20:169-177.